- Research
- Open access
- Published:
Comparison of the lethal triad and the lethal diamond in severe trauma patients: a multicenter cohort
World Journal of Emergency Surgery volume 20, Article number: 2 (2025)
Abstract
Background
To reduce the number of deaths caused by exsanguination, the initial management of severe trauma aims to prevent, if not limit, the lethal triad, which consists of acidosis, coagulopathy, and hypothermia. Recently, several studies have suggested adding hypocalcemia to the lethal triad to form the lethal diamond, but the evidence supporting this change is limited. Therefore, the aim of this study was to compare the lethal triad and lethal diamond for their respective associations with 24-h mortality in severe trauma patients receiving transfusion.
Methods
We performed a multicenter retrospective analysis of patients in TraumaBase®, a French database (2011–2023). The patients included in this study were all trauma patients who had received transfusions of at least 1 unit of red blood cells (RBCs) within the first 6 h of hospital admission and for whom ionized calcium measurements were available. Hypocalcemia was defined as an ionized calcium level < 1.1 mmol/L.
Results
A total of 2141 severe trauma patients were included (median age: 39, interquartile range [IQR]: 26–57; median injury severity score: 27, IQR: 17–41). Patients primarily presented with blunt trauma (81.7%), and a 24-h mortality rate of 16.1% was observed. Receiver operating characteristic curve analysis revealed no significant difference in the association with 24-h mortality between the lethal diamond (area under the curve [AUC]: 0.71) and the lethal triad (AUC: 0.72) (p = 0.26). The strength of the association with 24-h mortality was similar between the lethal triad and the lethal diamond, with Cramer’s V values of 0.29 and 0.28, respectively.
Conclusions
This study revealed no significant difference between the lethal triad and the lethal diamond in terms of their respective associations with 24-h mortality in severe trauma patients requiring transfusion. These results raise questions about the independent role of hypocalcemia in early mortality.
Background
Trauma is the primary cause of death in young adults (aged 15–49), with hemorrhage remaining a major cause of preventable early death [1, 2]. The management of severe trauma patients aims to prevent the onset of the lethal triad—comprising acidosis, coagulopathy, and hypothermia, and, if not, to combat the latter [2]. The lethal triad is closely associated with mortality in severe trauma patients [3,4,5,6]. This cascade culminates in a vicious cycle in which the combination of acidosis and hypothermia synergistically promotes coagulopathy, ultimately leading to death by exsanguination. The current definition of the lethal triad does not include hypocalcemia, another element that possibly interact with it [7,8,9]. But calcium is an essential cofactor for numerous physiological functions and enzymatic reactions, including coagulation, platelet adhesion, myocardial contractility, and vasomotor tone [8, 10,11,12]. Only ionized calcium (iCa) is biologically active; iCa is tightly regulated, with a physiological plasma concentration between 1.1 and 1.3 mmol/L [13]. Severe trauma patients may present with hypocalcemia even before the transfusion of blood products (BPs) [14, 15]. However, the transfusion of BPs can exacerbate hypocalcemia because of the citrate they contain [8, 16, 17]. In addition, hypothermia and hemorrhagic shock reduce the hepatic clearance of citrate, further aggravating ionized hypocalcemia [18, 19]. In trauma patients, hypocalcemia is associated with increased transfusion requirements [15, 20] and worse outcomes [21, 22]. As a result, some reports have suggested that the lethal triad should include hypocalcemia, forming the lethal diamond [23]. However, there is still insufficient evidence regarding the clinical importance of the lethal diamond compared to the lethal triad. Therefore, this study aimed to compare the lethal triad and lethal diamond for their respective associations with mortality in severe trauma patients. We hypothesized that the lethal diamond is associated with higher mortality than the lethal triad in this patient population.
Methods
Study design and setting
This study was a retrospective observational study of patients for whom data were prospectively collected in TraumaBase® between January 2011 and September 2023. TraumaBase® consecutively collects data on severe trauma patients across 26 trauma centers in France.
Participants
Trauma patients who received at least 1 unit of red blood cells (RBCs) during the first 6 h of hospital admission were included in the analysis. Patients admitted after secondary transfer [3] or aged < 15 years were excluded. Patients were also excluded when data for 24-h mortality or elements of the lethal diamond (minimum iCa, pH, prothrombin time ratio [PT ratio], and temperature over the first 24 h of admission) were missing or considered invalid.
Primary and secondary objectives
The primary objective of this study was to compare the respective associations of the lethal diamond and the lethal triad with 24-h mortality. The secondary objectives were to compare the associations of hypocalcemia with the other three elements of the lethal diamond (acidosis, hypothermia, and coagulopathy) and to describe the individual associations of hypocalcemia with morbidity and 24-h mortality.
Metrics
The following data types were collected: patient demographics (sex, age, injury mechanism, admission date, use of antiplatelet or anticoagulant medications, and time factors); clinical parameters; prehospital and admission data (blood pressure, heart rate, shock index, peripheral oxygen saturation, Glasgow Coma Scale [GCS], and temperature); treatments administered (mechanical ventilation, norepinephrine infusion, transfusion, fluid expansion, and tranexamic acid); and the results of admission laboratory tests (iCa, arterial lactate, pH, hemoglobin, PT ratio, platelet count, and fibrinogen level). iCa was measured as part of a blood gas test. Severity scores (Injury Severity Score [ISS] and abbreviated injury scale [AIS]); 24-h mortality rates; number and type of BPs (RBCs, fresh-frozen plasma [FFP]) administered within the first 6 and 24 h of care were recorded.
Definitions
Severe trauma patients were defined as those transfused with ≥ 1 unit of RBCs within 6 h post-trauma. Polytrauma according to Newcastle definition was defined with at least 2 body regions injured with AIS > 2 [24]. Traumatic brain injury (TBI) was defined as AIS of the head/neck > 3 [25, 26]. In the TraumaBase® registry, iCa recording criteria evolved: before 2020, it applied to patients receiving ≥ 4 units of RBCs within 6 h, and since 2020, to those receiving ≥ 1 unit of RBCs. The combination of acidosis, hypothermia, and coagulopathy formed the lethal triad [3], with hypocalcemia extending it to the lethal diamond [8]. Massive transfusion was defined as ≥ 6 RBC units within 6 h [27].
Elements of the lethal diamond
-
Hypocalcemia: minimum iCa < 1.1 mmol/L in the first 24 h [14, 19, 22, 23]
-
Acidosis: pH < 7.2 in the first 24 h [3]
-
Hypothermia: core temperature < 35 °C in the first 24 h [3, 24]
-
Coagulopathy: PT ratio < 70% in the first 24 h [25]
Analysis
Data were collected with Excel® version 16.9 (Microsoft Corporation, Redmond, Washington, USA). Statistical analyses were performed in R version 4.1.2 for Macintosh (R Foundation for Statistical Computing, Vienna, Austria). Data are expressed as medians (interquartile ranges [IQRs]) for quantitative variables and counts (percentages) for qualitative variables. For all tests, the significance threshold was set at p < 0.05. Categorical variables were analyzed with Fisher’s exact test or the Chi-squared test (with Yates’ continuity correction for binary variables), and continuous variables were analyzed with the Mann–Whitney U-test because of skewed distributions. In addition to performing Chi-squared tests, we also calculated Cramer’s V to estimate the effect sizes of correlations between 24-h mortality and the lethal triad or lethal diamond. Cramer’s V measures the association between two nominal variables and provides a value between 0 and 1 to indicate the strength of the relationship. It is particularly useful for Chi-squared tests, where it enables the interpretation of association effect sizes in contingency tables. Although Cramer’s V assesses the strength of an association without implying causation, logistic regression modeling facilitates predictions and inferences about causal relationships. Therefore, Cramer’s V is preferable when the focus is on understanding the strength and significance of the relationship between categorical variables without the need for prediction or inference about causation.
Receiver operating characteristic (ROC) curves were also analyzed, and the area under the ROC curve (AUC) was used to assess the performance of the lethal triad and the lethal diamond in predicting 24-h mortality. AUCs were compared with the DeLong test [28]. Each AUC and its corresponding standard error were estimated via 1000 bootstrap replicates. The confidence intervals were derived from the 2.5th and 97.5th percentiles of the bootstrapped AUC distribution, providing a nonparametric estimate of AUC uncertainty. Univariate and multivariate logistic regression analyses were performed to identify independent associations with mortality.
Ethics
TraumaBase® obtained approval from the Advisory Committee for Information Processing in Health Research (CCTIRS) from the National Commission for Data Protection (CNIL) and meets national institutional review board requirements (Comité de Protection des Personnes, Paris VI, Paris, France). Data are anonymized upon collection in case report files. This study received ethical approval (CER Paris Nord, Institutional Review Board number 00006477) and was declared to the CNIL (authorization number 2234099). The study is reported in accordance with STROBE and RECORD guidelines (see Additional file 2) [29].
Results
Patient selection
An analysis of the TraumaBase® registry revealed that 44 234 patients were registered between January 2011 and September 2023. Among them, 3594 severe trauma patients received at least 1 unit of RBCs within 6 h of hospital admission (Fig. 1). After patients with missing or invalid data were excluded, the final study cohort included 2141 patients. Of these, 24-h mortality data were not available for 134 patients.
Demographics and clinical characteristics
Tables 1 and 2 summarize the key characteristics of the study cohort. The median age was 39 years [26–57 years], with males accounting for 72.3% of the cohort. The median ISS was 27 [17–41], and the 24-h overall mortality rate was 16.1%. The primary cause of trauma was traffic accidents, accounting for 43.6% of patients. Blunt trauma was the most common mechanism of trauma (81.7%). A total of 51.5% of patients (n = 1072) had traumatic brain injuries, and 7.2% of patients (n = 152) required prehospital transfusions. Additionally, 126 patients (6.0%) received antiplatelet therapy, and 64 patients (3.1%) received anticoagulant therapy. However, when patients with and without hypocalcemia were compared, no significant difference was found with respect to the use of antiplatelet (p = 0.2) or anticoagulant (p = 0.4) therapy or in prehospital transfusion rates (p = 0.4). With respect to lethal diamond elements, the median values at 24 h were as follows: iCa: 1.0 mmol/L [0.9–1.1 mmol/L]; pH: 7.2 [7.1–7.3]; temperature: 35.0 °C [34.0–35.8 °C]; and PT ratio: 50% [35–62%] (Table 2).
A total of 60% of patients (n = 1240) met the Newcastle definition of polytrauma. 63% of them had hypocalcemia, 92% presented with coagulopathy, 60% experienced acidosis, and 56% suffered from hypothermia. Polytrauma patients, as defined by the Newcastle criteria, had a median ISS of 36 [27–45] and a 24-h mortality rate of 19.3%.
Primary objective
ROC analysis revealed that the associations of the lethal diamond (AUC 0.71; 95% CI 0.68–0.74) and the lethal triad (AUC 0.72; 95% CI 0.69–0.74) (p = 0.26) with 24-h mortality were not significantly different (Fig. 2). Furthermore, the strength of the association between mortality and the lethal triad (Cramer’s V: 0.29) was not significantly different from that between mortality and the lethal diamond (Cramer’s V: 0.28), with both showing a moderate association (range: 0.20–0.30).
Secondary objectives
Table 3 summarizes 24-h mortality rates according to the number of elements present in the lethal diamond and lethal triad. There were significant associations between 24-h mortality rates and both the lethal triad and the lethal diamond (p < 0.001) (Table 3). Table 4 shows the results of the univariate and multivariable analyses for 24-h mortality. In the univariate analysis, each element of the lethal diamond was significantly associated with 24-h mortality. Multivariate analysis of the lethal diamond elements revealed that hypocalcemia and 24-h mortality were no longer associated (odds ratio [OR]: 1.11; 95% CI 0.84–1.48; p = 0.5), in contrast to the other elements of the lethal diamond (p < 0.001 for each) (Table 4). In the multiple sensitivity analyses restricted to patients receiving more than 4 units of RBCs, excluding those with TBI, or focusing solely on patients undergoing massive transfusion, the findings remained consistent with those of the primary analysis (see Additional File 1).
Discussion
This study presents a comparative analysis of the well-documented lethal triad—comprising acidosis, coagulopathy, and hypothermia—and the more recently delineated lethal diamond, which includes the additional element of hypocalcemia, in relation to mortality rates among patients with severe trauma. Notably, the results of this study did not demonstrate a greater association of the lethal diamond with 24-h mortality over the lethal triad. While hypocalcemia showed no independent association with 24-h mortality, the other three elements individually maintained their associations. The lethal diamond concept, while addressing critical trauma-associated abnormalities, falls short of capturing the multifaceted nature of post-traumatic pathophysiology. Studies on trauma-induced coagulopathy emphasize the pivotal role of fibrinolytic imbalances and endothelial dysfunction, as reported by Moore et al. [30]. Simultaneously, insights from mitochondrial research underscore the profound impact of traumatic shock on global energy metabolism, driving cellular failure across multiple organ systems regardless of markers traditionally associated with the diamond model [31]. These findings highlight the need for a more comprehensive framework that integrates metabolic, vascular, and coagulation dimensions to inform the development of precise therapeutic strategies.
This study prompts reconsideration of the optimal endpoint for evaluating the utility of the lethal triad and diamond constructs. In accordance with literature demonstrating an early association of hypocalcemia with mortality, we focused on 24-h mortality [32].
Although substantial data exist on the incidence of the lethal triad and its association with mortality, comparative analyses with the lethal diamond remain limited. Our study addresses this gap, identifying the lethal diamond in 23.7% of severe trauma patients, with a 24-h mortality rate of 32.6%, comparable to that observed for the lethal triad. In multivariable analysis, the elements of the lethal triad remained significantly associated with increased 24-h mortality. However, when adjusted for other elements of the lethal diamond, hypocalcemia was not significantly associated with increased 24-h mortality, suggesting a potential interplay among these elements. Our findings align with those reported by Mackay et al. [7] and Chanthima et al. [33], in which hypocalcemia was not associated with increased mortality. Conversely, a recent multivariable analysis by Ciaraglia et al. revealed that hypocalcemia (< 1.00 mmol/L) was associated with a higher 24-h mortality rate (p = 0.003) [22]. Determining an explanation for the discrepancies across these studies remains complex. While the study populations exhibit similarities to our cohort regarding injury severity and the hypocalcemia threshold (ranging from 1.0 to 1.18 mmol/L), variability in methodologies complicates direct comparisons. Specifically, these studies lack standardization in the timing and protocol for ionized calcium (iCa) measurement after admission, as well as in calcium supplementation practices, contributing to the observed inconsistencies. Our cohort is notable for its high proportion of traumatic brain injury (TBI) cases. TBI-induced coagulopathy is a well-recognized risk factor for poor clinical outcomes [34]. However, we did not observe a significant difference in the association between mortality and the lethal triad versus the lethal diamond in patients without TBI (see Additional File 1). In this large French cohort, 64% of severe trauma patients developed hypocalcemia within the first 24 h of care. Recent studies have emphasized the intricate relationships among acidosis, hypothermia, coagulopathy, and hypocalcemia during hemorrhagic shock [13]. The precise role of hypocalcemia, whether because of trauma and transfusion or an early indicator of poor prognosis and escalated resuscitation needs, remains undetermined. Hypocalcemia commonly occurs following hemorrhage due to various mechanisms, including calcium chelation by phosphate released during tissue injury, transfusion with citrated BPs, and reduced hepatic clearance of citrate due to compromised hepatic perfusion, among other less understood mechanisms linked to shock [30]. Rushton et al. suggested that hypocalcemia may represent a normal physiological response to stress, facilitating coagulation and limiting postinjury apoptosis, and that excessive calcium administration could exacerbate these conditions [35]. Patients with hypocalcemia were more likely to develop coagulopathy and require MT, consistent with recent retrospective findings [20]. The existing literature highlights a strong link between hypocalcemia, more severe trauma-induced coagulopathy, and increased mortality following injury [13]. The risk of hypocalcemia increases with blood product transfusions, particularly in cases of liver injury. Addressing hypocalcemia may reduce the overall need for BPs and enhance the synergistic effect of resuscitation efforts [36]. However, Steele et al. reported no associations between calcium supplementation and improved calcium level normalization or reduced mortality [37]. Consequently, it is challenging to ascertain whether calcium level normalization can be attributed to calcium supplementation, overall patient management, or a combination of both. While severe hypocalcemia (< 0.84 mmol/L) may be clinically significant due to its association with cardiac arrhythmias [7], European guidelines recommend the administration of calcium to maintain iCa levels between 1.1 and 1.3 mmol/L [38]. Moreover, recent findings suggest that both hypocalcemia and hypercalcemia could influence the incidence of trauma-induced coagulopathy, transfusion requirements, and mortality, highlighting the importance of careful calcium monitoring and management [21]. Taken together, these findings underscore the need for future research aiming to develop standardized protocols for the recognition and management of hypocalcemia. Understanding the complex relationship between calcium and each element of the lethal triad is crucial for determining whether addressing hypocalcemia can reverse these abnormalities and improve outcomes. Although calcium is closely related to all lethal triad elements, the present study did not reveal sufficient evidence to consider hypocalcemia as a fourth, equal element in the form of the lethal diamond.
Our study has several limitations. First, its retrospective observational design inherently limits causal inference, allowing only the identification of associations. Hence, our results should be interpreted cautiously within their clinical context. In addition, iCa was not consistently recorded for all patients throughout the study period; it was only measured for those transfused with more than 4 units of RBCs until 2020, and for all patients transfused with more than 1 unit of RBCs thereafter. Consequently, during the second recording period, trauma patients possibly less severe were included in the analysis. However, when we only considered patients transfused with more than 4 units of RBCs, similar results to those of the main analysis were observed (see Additional File 1). Additionally, our study’s definition of severe trauma did not consider the rapidity of hemorrhage or the exact timing of transfusions within the initial 6 h of care, and the collection of missing information mirrors typical clinical settings where certain data may not be readily available. Moreover, the reliance on only the minimum recorded values of lethal diamond elements within the first 24-h period, particularly hypocalcemia, along with the lack of data on calcium supplementation and transfusion timing, presents interpretative challenges. Finally, the national scope of TraumaBase® introduces variability across medical centers concerning the timing, type, and dosing of calcium supplementation. The exclusion of patients with missing lethal diamond elements may also bias the extrapolation of results to a broader trauma population.
Conclusions
This study found no statistically significant differences between the lethal triad and lethal diamond regarding their associations with mortality. Hypocalcemia is just one of many factors that clinicians must monitor and address during resuscitation. Although the concepts of the lethal triad and lethal diamond can provide a useful framework, they may oversimplify the complexities of trauma hemorrhage. Clinicians should maintain vigilance over all factors influencing coagulopathy throughout the resuscitation continuum. These findings highlight the need for prospective interventional studies to better establish the prognostic value of hypocalcemia and determine optimal correction strategies.
Availability of data and materials
No datasets were generated or analysed during the current study.
Abbreviations
- AIS:
-
Abbreviated injury scale
- AUC:
-
Area under the curve
- BPs:
-
Blood products
- CCTIRS:
-
Comité Consultatif sur le Traitement de l’Information en matière de Recherche dans le domaine de la Santé (Committee for Information Processing in Health Research)
- CI:
-
Confidence interval
- CNIL:
-
Commission nationale de l'informatique et des libertés (National Commission for data protection)
- FFP:
-
Fresh-frozen plasma
- GCS:
-
Glasgow coma scale
- HR:
-
Heart rate
- iCa:
-
Ionized calcium
- IQR:
-
Interquartile range
- ISS:
-
Injury severity score
- BP:
-
Blood product
- LTE:
-
Lethal triad elements
- OR:
-
Odds ratio
- PT:
-
Ratio prothrombin time ratio
- ROC:
-
Receiver operating characteristic
- RBC:
-
Red blood cells
- SBP:
-
Systolic blood pressure
- STROBE:
-
Strengthening the reporting of observational studies in epidemiology
- TBI:
-
Traumatic brain injury
- RECORD:
-
Reporting of studies conducted using observational routinely-collected health data
References
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1736–88.
Stensballe J, Ostrowski SR, Johansson PI. Haemostatic resuscitation in trauma: the next generation. Curr Opin Crit Care. 2016;22(6):591–7.
Mitra B, Tullio F, Cameron PA, Fitzgerald M. Trauma patients with the “triad of death.” Emerg Med J EMJ. 2012;29(8):622–5.
Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular trauma–a unified approach. J Trauma. 1982;22(8):672–9.
Bozorgi F, Khatir IG, Ghanbari H, Jahanian F, Arabi M, Ahidashti HA, et al. investigation of frequency of the lethal triad and its 24 hours prognostic value among patients with multiple traumas. Open Access Maced J Med Sci. 2019;7(6):962–6.
Smith A, Hendrix V, Shapiro M, Duchesne J, Taghavi S, Schroll R, et al. Is the “death triad” a casualty of modern damage control resuscitation. J Surg Res. 2021;259:393–8.
MacKay EJ, Stubna MD, Holena DN, Reilly PM, Seamon MJ, Smith BP, et al. Abnormal calcium levels during trauma resuscitation are associated with increased mortality, increased blood product use, and greater hospital resource consumption: a pilot investigation. Anesth Analg. 2017;125(3):895–901.
Wray JP, Bridwell RE, Schauer SG, Shackelford SA, Bebarta VS, Wright FL, et al. The diamond of death: Hypocalcemia in trauma and resuscitation. Am J Emerg Med. 2021;41:104–9.
de Rocquigny G, Pasquier P. Calcium management in massive hemorrhage protocols. Injury. 2019;50(3):817–8.
Morgan JP, Perreault CL, Morgan KG. The cellular basis of contraction and relaxation in cardiac and vascular smooth muscle. Am Heart J. 1991;121(3 Pt 1):961–8.
Desai TK, Carlson RW, Thill-Baharozian M, Geheb MA. A direct relationship between ionized calcium and arterial pressure among patients in an intensive care unit. Crit Care Med. 1988;16(6):578–82.
De Robertis E, Kozek-Langenecker SA, Tufano R, Romano GM, Piazza O, Zito MG. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding. Minerva Anestesiol. 2015;81(1):65–75.
DeBot M, Sauaia A, Schaid T, Moore EE. Trauma-induced hypocalcemia. Transfusion. 2022;62(Suppl 1):S274–80.
Webster S, Todd S, Redhead J, Wright C. Ionised calcium levels in major trauma patients who received blood in the Emergency Department. Emerg Med J. 2016;33(8):569–72.
Magnotti LJ, Bradburn EH, Webb DL, Berry SD, Fischer PE, Zarzaur BL, et al. Admission ionized calcium levels predict the need for multiple transfusions: a prospective study of 591 critically Ill trauma patients. J Trauma Inj Infect Crit Care. 2011;70(2):391–7.
Li K, Xu Y. Citrate metabolism in blood transfusions and its relationship due to metabolic alkalosis and respiratory acidosis. Int J Clin Exp Med. 2015;8(4):6578–84.
Bunker JP, Bendixen HH, Murphy AJ. Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med. 1962;22(266):372–7.
Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137(1):209–20.
Maxwell MJ, Wilson MJA. Complications of blood transfusion. Contin Educ Anaesth Crit Care Pain. 2006;6(6):225–9.
Vettorello M, Altomare M, Spota A, Cioffi SPB, Rossmann M, Mingoli A, et al. Early hypocalcemia in severe trauma: an independent risk factor for coagulopathy and massive transfusion. J Pers Med. 2022;13(1):63.
Helsloot D, Fitzgerald M, Lefering R, Verelst S, Missant C, TraumaRegister DGU. Trauma-induced disturbances in ionized calcium levels correlate parabolically with coagulopathy, transfusion, and mortality: a multicentre cohort analysis from the TraumaRegister DGU®. Crit Care Lond Engl. 2023;27(1):267.
Ciaraglia A, Lumbard D, DeLeon M, Barry L, Braverman M, Schauer S, et al. Retrospective analysis of the effects of hypocalcemia in severely injured trauma patients. Injury. 2024;1:111386.
Ditzel RM, Anderson JL, Eisenhart WJ, Rankin CJ, DeFeo DR, Oak S, et al. A review of transfusion- and trauma-induced hypocalcemia: Is it time to change the lethal triad to the lethal diamond? J Trauma Acute Care Surg. 2020;88(3):434–9.
Butcher N, Balogh ZJ. AIS>2 in at least two body regions: a potential new anatomical definition of polytrauma. Injury. 2012;43(2):196–9.
Savitsky B, Givon A, Rozenfeld M, Radomislensky I, Peleg K. Traumatic brain injury: It is all about definition. Brain Inj. 2016;30(10):1194–200.
Rauch S, Marzolo M, Cappello TD, Ströhle M, Mair P, Pietsch U, et al. Severe traumatic brain injury and hypotension is a frequent and lethal combination in multiple trauma patients in mountain areas: an analysis of the prospective international Alpine Trauma Registry. Scand J Trauma Resusc Emerg Med. 2021;29(1):61.
Zatta AJ, McQuilten ZK, Mitra B, Roxby DJ, Sinha R, Whitehead S, et al. Elucidating the clinical characteristics of patients captured using different definitions of massive transfusion. Vox Sang. 2014;107(1):60–70.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg Lond Engl. 2014;12(12):1495–9.
Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, et al. Trauma-induced coagulopathy. Nat Rev Dis Primer. 2021;7(1):30.
Balogh ZJ. Polytrauma: acute acquired mitochondrial disease. Injury. 2023;S0020–1383(23):00417–25.
Hall C, Nagengast AK, Knapp C, Behrens B, Dewey EN, Goodman A, et al. Massive transfusions and severe hypocalcemia: an opportunity for monitoring and supplementation guidelines. Transfusion. 2021;61(Suppl 1):S188–94.
Chanthima P, Yuwapattanawong K, Thamjamrassri T, Nathwani R, Stansbury LG, Vavilala MS, et al. Association between ionized calcium concentrations during hemostatic transfusion and calcium treatment with mortality in major trauma. Anesth Analg. 2021;132(6):1684–91.
Zhang J, Zhang F, Dong J. Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury. Blood. 2018;131(18):2001–6.
Rushton TJ, Tian DH, Baron A, Hess JR, Burns B. Correction: Hypocalcaemia upon arrival (HUA) in trauma patients who did and did not receive prehospital blood products: a systematic review and meta-analysis. Eur J Trauma Emerg Surg. 2024;50(6):3353–3353. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00068-024-02544-5.
Kronstedt S, Roberts N, Ditzel R, Elder J, Steen A, Thompson K, et al. Hypocalcemia as a predictor of mortality and transfusion: a scoping review of hypocalcemia in trauma and hemostatic resuscitation. Transfusion. 2022;62:158–66.
Steele T, Kolamunnage-Dona R, Downey C, Toh CH, Welters I. Assessment and clinical course of hypocalcemia in critical illness. Crit Care Lond Engl. 2013;17(3):R106.
Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care Lond Engl. 2023;27(1):80.
Acknowledgements
The authors would like to warmly thank Anne Godier, Arthur James, Caroline Jeantrelle, Jacques Duranteau, Mathieu Raux, Nathalie Delhaye, Eric Meaudre, Jean-Luc Hanouz, Thomas Geeraerts, Sebastien Gette, Elisabeth Gaertner, Claire Jaillette, Cyril Delangue, and Clément Collard for their contributions to the research and their involvement in the TraumaBase®. The authors also thank Mrs. Horcholle for her invaluable help in extracting data from TraumaBase®. They also pay tribute to all the medical and surgical teams involved in the care of trauma patients, as well as to transfusion centers and blood donors.
The opinions or assertions expressed herein are the private views of the authors and are not to be considered as reflecting the official views of the French Military Medical Service.
Funding
This study received no funding.
Author information
Authors and Affiliations
Consortia
Contributions
CD, TM, OD and PP designed the framework of the article and drafted the manuscript. CD and TM collected and analyzed the data. TM and OD performed the statistical analysis. CD, TM, OD and PP verified the underlying study data. CD and TM generated figures and tables and refined the study design. CD, TM, OD, TG and PP provided final modifications to the manuscript. All authors contributed to manuscript revisions and approved the final manuscript as submitted.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
TraumaBase® obtained approval from the Advisory Committee for Information Processing in Health Research (CCTIRS) from the National Commission for Data Protection (CNIL) and meets national institutional review board requirements (Comité de Protection des Personnes, Paris VI, Paris, France). Data are anonymized upon collection in case report files. This study received ethical approval (CER Paris Nord, Institutional Review Board number 00006477) and was declared to the CNIL (Authorization Number 2234099).
Consent for publication
Not applicable.
Competing interests
Marc Leone served as a consultant for Viatris, Edwards, AOP Pharma, and MSD. Julien Pottecher for LFB. All the other authors have no conflicts of interest in relation to the submitted study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Dupuy, C., Martinez, T., Duranteau, O. et al. Comparison of the lethal triad and the lethal diamond in severe trauma patients: a multicenter cohort. World J Emerg Surg 20, 2 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13017-024-00572-5
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13017-024-00572-5